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ABSTRACT
THE EFFECT OF TISSUE DAMAGE AND INFLAMMATION ON GENE
EXPRESSION IN SENSORY NEURONS
Sean A Trusty
July 15,2011
This study examined the effects of tissue damage and inflammation on the expression in
sensory neurons of P2X3, a gene that has a role in nociception and sensing bladder
distension, which is regulated by nerve injury. Tissue damage induces expression of
ATF3, an indicator of injury, in sensory neurons. Animals were exposed to different
types of tissue damage including single and repeated skin incision, bladder incision and a
spinal cord injury with bladder inflammation. P2X3 was regulated differentially between
conditions of single and repeated skin incision. One condition that involves repeated
tissue damage and alteration of bladder function is spinal cord injury. In a small study of
SCI and bladder inflammation we found no change in P2X3 expression in sensory
neurons. Changes in expression of genes like P2X3 could have implications for bladder
dysfunction and altered nociception.
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INTRODUCTION

Nociception is defined as the neural processes of encoding and processing
noxious stimuli - those stimuli that are damaging or potentially-damaging, and normally
give rise to a sensation of pain. Nociceptive sensory neurons are responsible for
transmitting messages to the spinal cord that a stimulus is noxious and could potentially
lead to tissue damage (Julius and Basbaum, 2001). An important thing to realize is that
while a noxious stimulus may trigger an action potential it is just that, an electrical signal,
and must be processed by the brain to become perceived as pain. Nociception does not
necessarily equal pain. This work considers some mechanisms of changes in nociception
that can arise after tissue damage occurs.
Tissue damage is an every day risk for each of us. It can be as insignificant as a
little abrasion on your knee or as severe as a major trauma such as a gun shot wound. We
hope to avoid all of the tissue damage we possibly can, however we will all incur some
tissue damage at some point in our lives.
Tissue damage can come in many forms and it often leads to pain (Julius and
Basbaum,2001). In addition to pain tissue damage can also affect sensory neurons
causing gene expression changes that are similar to nerve injury. Incising the cutaneous
tissue without cutting a nerve mimics nerve injury by inducing the expression of ATF3 in
the cell bodies of neurons in the dorsal root ganglia (Hill et aI., 2010). Cutaneous tissue
incision also leads to up regulation of neuronal regenerative markers (Hill et aI., 2010).
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Other studies have also shown that peripheral application of noxious chemicals such as
capsaicin, formalin, mustard oil and menthol activate ATF3 in neurons (Braz and
Basbaum, 2010). These two studies may imply that injury to axons in tissue without
injury to the nerve itself may be adequate to lead to an injury-like response in the
neurons.
Following injury to neurons certain processes can lead to sensitization. This
sensitization can take the form of increased response to stimuli and/or lowered threshold
to stimuli (i.e. hyperalgesia) and possibly playa role in making non-noxious stimuli
become noxious (i.e. allodynia) (Basbaum and Woolf, 1999). These stimuli are
transduced and communicated to the spinal cord in the form of action potentials fired
from sensory neurons (Julius and Basbaum, 2001). Sensitization results in increased
action potential frequency.
Injury to sensory neurons induces a priming effect in terms of axonal
regeneration. That is, a second injury to the neuron results in a greater amount of axonal
regeneration (Neumann et aI., 2005). This will be referred to as anatomical priming.
However, this is not the only form of priming that may occur. Another form of priming
can occur from prolonged inflammation leading to nociceptor sensitization. Priming can
be caused by release of proinflammatory mediators, which includes prostogladin E2 and
adenosine (Ferrari et aI., 2010) and we will call this neurochemical priming. Injury and
inflammation can lead to priming of sensory neurons that not only cause increased
expression of genes related to axonal regeneration but also neuroplastic changes.
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Gene changes that occur after injury to sensory neurons can be important in terms
of nociception. These changes can be reflected in neuronal anatomy, neurochemistry and
function (i.e. transduction and signaling). A gene that is important for nociceptive
transduction is purinoreceptor 3, or P2X3. P2X3 receptors on axon terminals in the
periphery bind ATP released from peripheral tissues and transduce a signal by
nociceptive neurons that can be carried by primary afferent neurons to the spinal cord and
on to the brain to be perceived as painful (Hamilton and McMahon, 2000, Chizh and
Illes, 2001, North, 2004). P2X3 has also been found to playa role in different pain states
including inflammatory, neuropathic and visceral pain (Chizh and Illes, 2001). Knockout
mouse studies have demonstrated a vital role for P2X3 in peripheral nociception as well
as bladder function. P2X3 knockout mice have reduced pain related behavior when ATP
and noxious chemicals such as formalin are injected into the hind paw (Cockayne et aI.,
2000).
P2X3 knockout mice also exhibit largely distended bladders, bladder
hyporeflexia, and decreased voiding frequency (Cockayne et aI., 2000) associated with a
reduced capacity for transducing the ATP-mediated signal of distension. Normal bladder
function relies on peripheral receptors and a nervous system circuit to monitor bladder
fullness so we can determine when it is time to "go." The bladder is a hollow organ with
a urothelium and a muscular wall. When the bladder is filling the walls begin to stretch
to accommodate the increased amount of urine that is filling the bladder. As the walls
stretch the urothelium releases ATP to signal distension (Burnstock, 2009). A
purinoreceptor P2X3, binds ATP and transduces the release of ATP into a neural signal
(Dunn et aI., 2001) that is carried by primary afferents to the spinal cord and brain to tell
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us, "my bladder is getting full." While P2X3 binds ATP and transmits the signal of
stretch in the bladder, as well as being expressed by some nociceptors, which transmit
primary sensory information to the spinal cord and brain which could be perceived as
pain (Cook and McCleskey, 2000, Burnstock, 2009). The characteristics of the P2X3
knockout mouse indicate a vital role for P2X3 in nociception and bladder function. One
condition which caries issues of enhanced nociception and pain, repeated tissue damage
and bladder dysfunction is spinal cord injury.
Every year approximately 12,000 people suffer a spinal cord injury (Center,
2011). Loss of locomotion is a very severe consequence that occurs after spinal cord
injury (SCI), however that is only one of the multiple problems the individual will face
following injury that will decrease the individual's quality of life. Other problems facing
the patient include the possible loss of sensory and autonomic functions below the level
of the injury. Bladder and sexual dysfunction of the injured patient rank among the top
problems affecting the SCI population (Anderson, 2004). In addition to affecting quality
of life, mortality is also affected with an individual with a spinal cord injury being 11
times more likely to die of diseases of the urinary system than individuals without SCI
(DeVivo MJ, 1995).
Incontinence, the need for catheters and the infections associated with them are
troublesome issues a SCI patient must face following injury itself. In addition to these
issues of the urinary system is the incidence of pelvic pain in some individuals following
the injury. While every SCI is unique in terms of level and mechanism of injury, many
individuals face some kind of sensory deficit below the level of the injury. Spinal cord
injured individuals also face many potential sources of tissue damage. Reoccurring need
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for catheters and pressure sores often plague the individual (McKinley et aI., 1999).
While non SCI individuals occasionally encounter these same issues their nervous system
is able to sense noxious stimuli allowing them to perceive the symptoms and seek the
necessary treatment to alleviate these issues and treat them without incurring many
complications such as systemic infections and tissue damage. Non SCI individuals also
have descending pain-modulation circuitry which can suppress the effect of the input
from nociceptors on the spinal cord (Sandkuhler, 1996, Gebhart, 2004).
While the SCI patient often does not have sensation below the level of the injury,
it does not mean that stimuli and the resultant sensory input to the spinal cord cease to
exist. While the message is not making it to the brain to tell you "ouch that hurts," the
message is still being sent by sensory neurons and processed by the spinal cord. While
the painful stimulus exists the nociceptors are stilling working hard doing their job
sending a message that will never be received by the brain. Reoccurring urinary tract
infections, gastro intestinal problems and bedsores are just a few of the stimuli leading to
the triggering of nociceptors. These signals while not producing the pain that a non-SCI
patient would feel are not occurring without consequence. Nociceptive input can lead to
sensitization and serious conditions such as autonomic dysreflexia. Autonomic
Dysreflexia is triggered by changes in the sensory neurons after repeated signaling that
allows a stimulus such as bladder distension to become the trigger for a dangerous rise in
blood pressure that can cause severe and even fatal myocardial infarctions and strokes
(Teas ell et aI., 2000). Bladder over distension is only one of the noxious stimuli that can
cause autonomic dysreflexia to occur. Other conditions that can lead to autonomic
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dysreflexia that an SCI individual may have are urinary tract infections and pressure
sores (Teasell et aI., 2000).
Following SCI, many changes such as bladder hypertrophy, detrusor
hyperreflexia, urinary tract infections and neurogenic bladder dysfunction come about in
the urinary system (Lu et aI., 2007). These changes may lead to repeated noxious stimuli
leading to the sensitization of not only the bladder but also the sensory innervation to the
bladder itself. Many of these changes can affect the sensory afferents of the bladder. The
plasticity of sensory neurons may be caused by neurotrophic factors such as NGF that is
at a higher concentration in bladder tissue after SCI (de Groat and Yoshimura, 2010).
This plasticity can affect the neurons in many different ways, altering them
morphologically, chemically and electrically (de Groat and Yoshimura, 2010). Urinary
tract infections, detrusor hyperreflexia, autonomic dysreflexia, as well as neurogenic
bladder dysfunction occur after SCI. It is also known that after SCI, the bladder is
hypertrophied and has increased capacity (Lu et aI., 2007). Combined with these
morphological changes in the bladder, hypersensitivity in neurons can lead to changes in
sensory input from the bladder. The changes that can occur in sensory neurons of an
inflamed bladder are increased excitability and sensitization of the neurons innervating
the bladder (Dang et aI., 2008).
Two spinal cord regions receive sensory innervation/information from the
bladder. The Ll and L2 spinal segments receive sensory innervation from the dome of
the bladder while L6 and S 1 receive innervation from the wall of the bladder (Applebaum
et aI., 1980). The L6 and S 1 spinal segment receives information from the pelvic nerve,
which is important for the sensation of bladder distention. The Ll and L2 segment
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receives information from the hypogastric nerves and it responds to bladder distension as
well as being more responsive to chemical irritation/damage than the pelvic nerve (Moss
etaI.,1997).
The role of P2X3 in nociceptive signaling has been outlined in both visceral and
somatic systems. P2X3 expression levels have been shown to vary following injury to
peripheral neurons (Tsuzuki et aI., 2001), which results in the induction of activating
transcription factor (ATF3) (Tsujino et aI., 2000). What is interesting about P2X3 and
A TF3 is that they may have a relation to one another. The gene coding for P2X3 has a
putative binding site for ATF3 (Subramanian et aI., 2005). Thus, P2X3 may be regulated
in some manner by ATF3 activation following injury to neurons. It was shown that
following peripheral nerve injury that while mRNA levels of P2X3 in the entire dorsal
root ganglion may be elevated, P2X3 expression in neurons that also expressed ATF3
was greatly reduced (Tsuzuki et aI., 2001). Thus, non-injured neurons in the same dorsal
root ganglia as the neurons that were injured can increase P2X3 mRNA expression while
the injured neurons decrease P2X3 expression.
This study examines the changes in gene expression of a transcription factor
ATF3 and a nociceptive related transduction channel P2X3 in various tissue injury
conditions. The expression of genes such as A TF3 is a good indicator of neuronal injury
because it is absent before injury, and A TF3 is required for successful regeneration (Starn
et aI., 2007). Various single cutaneous tissue incision time points as well as multiple
incisions examined to see what effect they may have on neurons in terms of injury and
nociception. Bladder incision in an animal without SCI will also be examined to see
what effect visceral tissue damage has on sensory neurons. A SCI plus inflammation
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study will examine the effect that SCI and inflammation has on neurons innervating the
bladder in terms of neuronal injury and the expression of nociceptive markers.
The question we study is what happens to those markers of nociception and
neuronal injury after injury and inflammation in cutaneous tissue and the bladder. The
hypothesis is that following injury to the bladder and cutaneous tissue that gene
expression will be affected with ATF3 being expressed by injured neurons and P2X3
being down regulated after tissue damage and that after repeated injury and inflammation
that P2X3 expression will be reduced even more.
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MATERIALS AND METHODS
All animal procedures were reviewed and approved by the Institutional Use and
Care Committee and carried out at the University of Louisville, School of Medicine.

Single Skin Incision
For the single skin incision study, a 3cm-Iong rostrocaudal incision was made
1cm to the right of midline in the dorsal thoracic hairy skin (-T3-T8 dermatome;
including the attached underlying cutaneous trunci muscle). This location prevented
accidental injury to the dorsal cutaneous nerves themselves. The skin was then closed
with surgical staples. Animals received Lacrilube ointment in their eyes, an intramuscular
injection of 0.1 cc gentamycin (left gastrocnemius muscle), an intraperotineal injection of
5 cc lactated Ringer's solution, and Animax antibacterial/antifungal ointment applied
directly to the wound. Different time points were allowed to pass following skin incision
before the animal was sacrificed and the dorsal root ganglia corresponding to the incision
were collected. The time points were 4, 7, 14, 28 days after incision. The dorsal root
ganglia RNA was extracted converted to cDNA and was then run for PCR for the gene
P2X3.
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Table 1: Single Skin Incision Time Table

Single
Skin
Incision

Treatment
Dates

Groups

Day 0

Day 4

4 Day
n=3

Skin Incision

Tissue
Retrieval

7 Day
n=3

Skin Incision

14 Day
n=3

Skin Incision

28 Day
n=3

Skin Incision

NaIve
n=3

Tissue
Retrieval

Day 7

Day 14

Day 28

Tissue
Retrieval
Tissue
Retrieval
Tissue
Retrieval

Bladder Incision
For the bladder incision study, a total of four naIve animals underwent an
abdominal surgery to incise the dome of the bladder with microscissors. The L11L2
dorsal root ganglia were collected. RNA was extracted turned into eDNA and qPCR was
run for the gene P2X3. NaIve n of 3.

Double Incision
For the initial injury, a 3cm-Iong rostrocaudal incision was made 1cm to the right
of midline in the dorsal thoracic hairy skin (-T3-T8 dermatome; including the attached
underlying cutaneous trunci muscle). This location prevented accidental injury to the
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dorsal cutaneous nerves themselves. For animals receiving two injuries, a second skin
incision was made, 1 mm lateral from the initial incision, at either 14 days or 28 days
after the intial incision. The skin was then closed with surgical staples. Animals received
Lacrilube ointment in their eyes, an intramuscular injection of 0.1 cc gentamycin (left
gastrocnemius muscle), an intraperotineal injection of 5 cc lactated Ringer's solution, and
Animax antibacterial/antifungal ointment applied directly to the wound. Four days after
the second incision was made the animals were sacrificed and the dorsal root ganglia
corresponding to the incised skin were collected.
Table 2: Double Skin Incision Time Table
Double Skin
Incision
Groups

Day 0

Day 14

Day 18

14+4Day
n=7

Skin
Incision

Repeat
Incision

Tissue
Retrieval

28 +4 Day
n=7

Skin
Incision

NaIve n=4

Tissue
Retrieval

Day 28

Day 32

Repeat
Incision

Tissue
Retrieval

Spinal Cord Injury

In the Spinal Cord Injury with Bladder Inflammation study 12 male Wistar rats
were used in the study. A total of 8 of the 12 rats received a T8 spinal cord transection
on day 1 of the study with the other 4 being naIve. Eight animals were anesthetized with
a mixture of ketamine (80 mg/kg body weight; Fort Dodge Animal Health, Fort Dodge,
IA) and xylazine (10 mg/kg body weight; Akorn Inc, Decatur, IL) injected
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intraperitoneally. The spinal cord was exposed by laminectomy of the T7 vertebra,
which lies over the T8 portion of the spinal cord. Spinal cord transection was made using
microscissors to make a complete transverse lesion of the cord. The lesion was inspected
following the transection to insure completeness. A piece of gel foam was placed
between the rostral and caudal sections of the spinal cord and a piece of dura film was
placed over the lesion before the incision was closed.

Spinal Cord Injury Care
The rats receiving a SCI were given a sub cutaneous injection of 3 mL of saline
for hydration immediately following the spinal cord transection. The rats were also given
a 0.5 mL sub cutaneous injection of Pro Pen G on day 1 for prevention of infection.
Starting on day 1 the rats were given a sub cutaneous injection of Ketoprofen (2.5 mg/kg
body weight; Fort Dodge Animal Health), twice a day for 2 days for analgesia. Also
starting on day 1 the rats were given a sub cutaneous injection of Gentamycin (5 mg/kg
body weight; Hospira Inc, Lake Forest, IL) once a day for 5 days for prevention of
possible bladder infection. Following surgery the each animal's bladder was expressed
two times a day for 10 days until they became able to void on their own. Surgical clips
were removed 7 days after surgery. The general condition of the animal was checked and
the perineal area cleaned each time bladder expression was performed.

The SCI rats

were allowed to recover for 30 days.

Bladder Catheterization
On day 31 post SCI the rats had a catheter (PE 60, 3.5" length, Intramedic
Polyethlene Tubing, Becton Dickinson, Sparks, MD) placed in their urinary bladder to
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allow for the infusion of either 0.5 percent acetic acid mixed with 0.9 percent normal
saline or 0.9 percent normal saline alone. The catheter placement was done under 2%
isoflurane (Baxter, Deerfield, IL) sedation. The catheter placement was made by making
a 3 cm midline abdominal incision followed by blunt dissection of the midline abdominal
muscles to allow access to the peritoneal cavity. After accessing the peritoneal cavity a
purse string suture made with 5.0 nylon was placed in the dome of the bladder and the
bladder was incised with microscissors (FST). The catheter was then placed through the
incision into the bladder and the purse string suture was tied to anchor the catheter which
had a cuff placed at the end. The catheter was tunneled under the skin and exited the rat
through an incision just off midline on the dorsum of the rat between the shoulder blades
where it was capped and the skin closed with surgical clips (Leica) so future infusions
could be made. The abdominal incision was closed in layers. Following the
catheterization surgery the animals were given a 0.5 mL sub cutaneous injection of Pro
Pen G for prevention of infection. They were also given a 5mg/kg sub cutaneous
injection of Gentamycin once a day for 5 days for prevention of infection.
Bladder Infusion
Infusions were on days 31, 33, 35 post SCI. Each infusion had a volume of 1 mL
of the desired solution, either 0.5% acetic acid or 0.9% normal saline and the infusion
was performed under 2% isoflurane sedation. Each infusion lasted 30 minutes and was
followed by manual expression of the bladder and by flushing of the urinary bladder with
two, 1 rnL infusions of 0.9% normal saline followed by manual expression of the bladder.
Following the infusion on day 35, the rat was allowed to survive 2 days and was
sacrificed on day 37.
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Tissue Retrieval
For mRNA expression studies, the rats were perfused with 33 percent RNA Later
(Ambion) in exsanguination solution (2.7L distilled water, 27g NaC!, 5.1g Sodium
Phosphate monobasic, 42.9g Sodium Phosphate dibasic, total volume 3L). Following
perfusion, the nodose ganglia followed by the L6/S1 and LIIL2 dorsal root ganglia, and
urinary bladder were extracted. All tissues were placed in RNA later and flash frozen in
liquid nitrogen and kept in -80 degree Celsius until RNA extraction. Tissue was
collected on 4 SCI animals and 4 naive animals.
Table 3: SCI + Bladder Inflammation Time Table

SCI + Bladder
Inflammation

Treatment
Dates

Groups

Day 1

Day 31

Day 31

Acetic Acid
n=2

T8 Transection

Bladder Catheterization

Acetic Acid
Infusion

T8 Transection

Bladder Catheterization

Normal Saline
Infusion

Day 33

Day 35

Day 37

Acetic Acid
n=2

Acetic Acid
Infusion

Acetic Acid Infusion

Tissue
Retrieval

Normal Saline
n=2

Normal Saline
Infusion

Normal Saline
n=2

Normal Saline Infusion

Tissue
Retrieval
Tissue
Retrieval

Naive n=3
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Table 4: SCI + Bladder Inflammation Level Effected

SCI + Bladder Inflammation

Level Effected (DRG)

Abdominal Incision·

L11L2 (Presumed)

Bladder Catheterization

L11L2

Acetic Acid Infusion

L11L2, L6/S 1

Normal Saline Infusion

L11L2, L6/S 1

RNA Extraction and Quantitative peR
Dorsal root ganglia (DRG) and nodose Ganglia housing neurons innervating the
incised tissue were then retrieved. In the SCI + Bladder Inflammation study the L11L2
and L6/S 1 DRG were pooled by animal. In the skin incision study the DRG innervating
the incised area were pooled as well. Pooled samples were homogenized on ice using a
motorized dual teflon glass homogenizer for 1 minute in 350 ul buffer RLT (Qiagen,
Valencia, CA) and 2-mercapto-ethanol. RNA was extracted from the homogenates using
the RNeasy plus micro kit (Qiagen) as per manufacturer's protocol. Briefly,
homogenates were cleared by centrifugation before selective removal of genomic DNA
using the DNA eliminator affinity spin column. RNA was purified by affinity
purification using RNA spin columns and eluted in 14 mL of nuclease-free water. RNA
integrity was assessed by UV spectrometry and using a Bioanalyser (Agilent
Technologies, Santa Clara, CA). A RNA clean up step was performed with 5M
ammonium acetate, glycogen and ethanol precipitation. RNA sample integrity was then
reassessed. RNA samples with 260 nml280 nm ratios above 1.9 and 260 nml230 nm
ratios and RNA integrity numbers (RINs) above 1.8 met quality-control standards and
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were used for quantitative PCR.

Quantitative Real-Time peR

cDNA was synthesized by addition of reverse transcriptase and reaction buffer.
cDNA was synthesized at 25 degrees C for 5 minutes, 42 degrees C for 30 minutes and
the reverse transcriptase subsequently deactivated by heating to 85 degrees C for 5
minutes. 5 ng of cDNA template was provided for each PCR reaction (carried out in
triplicate). SYBR green QPCR was carried out using a Rotorgene real time PCR
detection instrument (Corbett Research, Sydney, Australia). Gene expression values
were calculated against the internal reference gene GAPDH. Small differences in QPCR
reaction efficiency between primer sets were accounted for using the standard curve
quantification method.

Primers
The P2X3 forward primer sequence was 5' GGCAAGTTCAACATCATCCC and
the reverse was 5' AGTCACCTCCTCAAACTTCC. The ATF3 forward primer
sequence was 5' GAGATGTCAGTCACCAAGTC and the reverse
5' TTCTTCAGCTCCTCGATCTG.

Data Analysis
Data analysis was performed in Microsoft Excel and Sigmaplot. Statistics were
performed in SPSS and Sigmaplot using one-way ANOVA and post hoc student's t-tests.
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RESULTS

Single Skin Incision
Following single skin incision P2X3 rnRNA levels appear to decrease at 4 days
and remain decreased at 7 and 14 days and return towards baseline at 28 days. A oneway ANOVA determined that there are not significant differences at any time point
compared to naIve or each other.
Figure 1:

Single Skin Incision P2X3 mRNA Expression
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Figure 1: P2X3 rnRNA Expression in TSff6ff7 Dorsal Root Ganglia Following a Single
Skin Incision. Values are mean P2X3 rnRNA expression for naIve, 4, 7, 14 and 28 day
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timepoints after a single skin incision (relative units adjusted to naive, normalized to
GAPDH). Error bars indicate standard deviation. All groups n = 3
Double Skin Incision
A double incision study was also conducted to examine the effects of repeated
tissue injury on P2X3 expression. The mRNA levels of P2X3 went from appearing to be
down regulated versus naIve in single incision to appearing to be slightly up regulated
versus naIve. However, statistical analysis with a one-way ANOV A determined that
there are no statistical differences from naIve at either time point or each other.
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Figure 2:

Double Skin Incision P2X3 rrRNA. Expression
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Figure 2: P2X3 mRNA Expression in T5fT6fT7 Dorsal Root Ganglia Following a Double
Skin Incision. Values are mean P2X3 mRNA expression for naIve, 14+4 and 28+4 day
timepoints after a double skin incision (relative units adjusted to naive, normalized to
GAPDH). Error bars indicate standard deviation. NaIve n =4, 14+4 n = 7 and 28+4 n =
7.

Single Skin Incision versus Double Skin Incision
Although statistical analysis indicated no significant difference in P2X3 mRNA in
either condition compared to naIve, we sought to determine if the regulation of P2X3
mRNA differed in those conditions. We found that there was a statistical difference
(Student's t-test p <0.05) when single skin incision was compared to double skin incision.
The fold changes of each animal were used to calculate a mean fold changes for each
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experimental group and the results were compared. 14 Day Single Skin Incision was
compared to 14 + 4 Day Double Skin Incision and 28 Day Single Skin Incision was
compared to 28 + 4 Day Double Skin Incision. The 4 day single skin incision is shown
as well for comparison to the 14 + 4 and 28 + 4 Day Double Skin Incision.
Figure 3:
14 Day Single Skin Incision vs 14 + 4 Day Double Skin Incision
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Figure 3: 14 Day Single Skin Incision vs. 14 + 4 Day Double Skin Incision. Values are
mean P2X3 fold change for 14 Day Single Incision and 14+4 Day Double Skin Incision.
4 Day n = 3, 14 Day n = 3 and 14+4 n = 7. Error bars indicate standard deviation.
Student's t-test p < 0.05
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Figure 4:

28 Day Single Incison vs 28 + 4 Day Double Incison
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Figure 4: 28 Day Single Skin Incision vs. 28 + 4 Day Double Skin Incision. Values are
mean P2X3 fold change for 14 Day Single Incision and 14+4 Day Double Skin Incision.
4 Day n = 3, 28 Day n = 3 and 28+4 n = 7. Error bars indicate standard deviation.
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Student's t-test p < 0.05
Bladder Incision
In order to determine whether the regulation of P2X3 after skin incision also
occurred for damage of visceral tissue, the bladder was incised. It was found that
following bladder incision expression levels of P2X3 appear to be reduced. Statistical
analysis (Student's t-test) indicated no statistical difference between the two groups but it
is approaching significance with a p = 0.053. This trend towards reduction follows a
similar trend to cutaneous tissue injury for P2X3 expression levels.

21

Figure 5:
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Figure 5: P2X3 mRNA Expression in LIIL2 Dorsal Root Ganglia Following Bladder
Incision. Values are mean P2X3 mRNA expression for naIve and bladder incised
animals (relative units adjusted to naive, normalized to GAPDH) . Error bars indicate
standard deviation. NaIve n = 3, Bladder Incised n =4.

SCI plus Bladder Inflammation
In the study with animals receiving a spinal cord transection and bladder
inflammation levels of P2X3 appeared to be variable with respect to location, LIIL2
versus L6/S 1, however neither result was found to be significant with a one-way
ANOV A. ATF3 expression was significant in the LIIL2 dorsal root ganglia but not at
L6/S 1 using a one-way ANOV A. It was not evident from the data that the acetic acid
mediated inflammation caused any difference in the P2X3 or ATF3 levels in the acetic
acid versus the normal saline treated animals. The nodose ganglia did not appear to have
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any change for inflamed or non-inflamed SCI rats versus naIve rats for levels of P2X3 or
ATF3.

Effect of Segment on gene regulation with bladder damage
In order to determine the effect SCI and bladder inflammation has on gene

expression, qPCR was run for P2X3 and ATF3 in the LIIL2 and L6/S 1 dorsal root
ganglia and nodose ganglia. For the L lIL2 dorsal root ganglia, we found that ATF3
expression was significantly up regulated in both the acetic acid and normal saline treated
animals as compared to naIve in the LIIL2 dorsal root ganglia (Figure 6). However,
P2X3 expression was found to have no change in the LIIL2 dorsal root ganglia (Figure
7). For the L6/S 1 dorsal root ganglia, ATF3 expression was not significantly up
regulated in the L6/S 1 dorsal root ganglia for either the acetic acid or normal saline
treated animals as compared to naIve (Figure 8). P2X3 expression in the L6/S 1 dorsal
root ganglia also had no change for the acetic acid or normal saline treated animals as
compared to naIve (Figure 9). We also accessed vagal sensory innervation of the bladder
from the nodose ganglia and found there was no change for ATF3 or P2X3 expression in
the nodose ganglia in acetic acid treated as compared to naIve animals (Figure 10 and
11).
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Figure 6:
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Figure 6: ATF3 rnRNA Expression in L11L2 Dorsal Root Ganglia Following SCI +
Bladder Inflammation. Values are mean ATF3 rnRNA expression for naIve, acetic acid
and normal saline treated after SCI (relative units adjusted to naive, normalized to
GAPDH). Error bars indicate standard deviation. NaIve n =3, Acetic Acid n = 2 and
Normal Saline n = 2. * = Student's t-test p<O.05 .
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Figure 7:
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Figure 7: P2X3 mRNA Expression in LIIL2 Dorsal Root Ganglia Following SCI +
Bladder Inflammation. Values are mean P2X3 mRNA expression for naive, acetic acid
and normal saline treated after SCI (relative units adjusted to naive, normalized to
GAPDH). Error bars indicate standard deviation. Naive n =3, Acetic Acid n = 2 and
Normal Saline n = 2.
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Figure 8:
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Figure 8: ATF3 mRNA Expression in L6/S 1 Dorsal Root Ganglia Following SCI +
Bladder Inflammation. Values are mean ATF3 mRNA expression for naIve, acetic acid
and normal saline treated after SCI (relative units adjusted to naive, normalized to
GAPDH) . Error bars indicate standard deviation. NaIve n =3 , Acetic Acid n = 2 and
Normal Saline n = 2.
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Figure 9:
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Figure 9: P2X3 mRNA Expression in L6/S 1 Dorsal Root Ganglia Following SCI +
Bladder Inflammation. Values are mean P2X3 mRNA expression for naive, acetic acid
and normal saline treated after SCI (relative units adjusted to naive, normalized to
GAPDH) . Error bars indicate standard deviation. NaIve n =3 , Acetic Acid n = 2 and
Normal Saline n = 2.
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Figure 10:
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Figure 10: ATF3 mRNA Expression in Nodose Ganglia Following SCI + Bladder
Inflammation. Values are mean ATF3 mRNA expression for naive, acetic acid treated
after SCI (relative units adjusted to naive, normalized to GAPDH). Error bars indicate
standard deviation. Nai've n =3 , Acetic Acid n = 1.
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Figure 11 :
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Figure 11: P2X3 rnRNA Expression in Nodose Ganglia Following SCI + Bladder
Inflammation. Values are mean P2X3 rnRNA expression for naIve, acetic acid treated
after SCI (relative units adjusted to naive, normalized to GAPDH). Error bars indicate
standard deviation. NaIve n =3 , Acetic Acid n = 1.
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Table 5: Summary of P2X3 Expression by Experiment
Experiment

P2X3 mRNA Expression

Single Skin Incision vs. Naive·

No Change

Double Skin Incision vs. Naive

No Change

Bladder Incision vs. Naive

Down (Approaching Significance)
p = 0.053

(14,28 Day) Single Skin vs. (14+4,28+4
Day) Double Skin Incision

Differential Regulation p < 0.05

SCI+Bladder Inflammation LIIL2

No Change

SCI+Bladder Inflammation L6/S 1

No Change

SCI+Bladder Inflammation Nodose

No Change
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DISCUSSION
Skin Incision

We do not know the mechanism of P2X3 regulation following tissue injury. In
the cutaneous injury models P2X3 expression follows a clear though not statistically
different trend by apparently decreasing following initial tissue incision followed by an
apparent recovery as the time course extends. After repeated incision of the skin P2X3
actually "reverses" its regulation and increases after second tissue incision. There is a
statistically significant difference between the single skin incision and double skin
incision groups when comparing the 14 and 14 + 4 day groups and the 28 and 28 + 4 day
groups. This difference may indicate a switch that could lead to potential pathological
changes in sensory neuron function. A switch that may be an indicator of functional
priming, which is different then the anatomical and neurochemical priming we discussed
earlier. P2X3 up regulation could lead to increased nociceptive signaling.
Bladder Incision

In the bladder incision without SCI study, P2X3 values are approaching
significance with a decrease in expression. While not statistically significant this follows
the trend of P2X3 mRNA expression decrease following an initial tissue insult in visceral
tissue as well as somatic. Bladder damage might induce damage to sensory neurons.
Damage to sensory neurons may lead to changes in gene expression specifically P2X3 in
the sensory afferents that innervate the bladder. We have shown that bladder damage
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(i.e. bladder incision) does increase ATF3 expression in sensory neurons innervating the
bladder. Bladder inflammation has been shown to sensitize bladder afferents and
enhance P2X3 function (Dang et aI., 2008), which could lead to bladder hypersensitivity
and overactivity. While bladder damage decreases P2X3 expression in bladder afferents,
which could lead to bladder dysfunction.

Bladder inflammation with chronic SCI
P2X3 expression in response to SCI and bladder inflammation does not decrease
like it does in bladder incision and single skin incision. It trends towards being slightly
down regulated at the LIIL2 level and slightly up regulated at the L6/S 1 level. However,
there is no statistical difference when P2X3 expression is compared for the LIIL2 vs.
L6/S 1 acetic acid treated animals. A question is could SCI and the general havoc that it
creates, particularly in terms of bladder distension and tissue damage be acting as a
primary injury to the bladder. With the distension, ATP is being released by the bladder
urothelium for P2X3 receptors to bind and transduce a signal (Burnstock, 2009). More
distension could equal more ATP which creates a more intense neural signal than naIve.
This increased signal could be acting as a primary insult with the insertion of catheter and
irritation by inflammatory agent acting as a secondary injury. This scenario may explain
why we would not see a significant decrease in P2X3 following bladder incision and
inflammation due to the addition of SCI and the resultant bladder hypertrophy or SCI
itself could be acting as a primary injury. Thus, this scenario may act as multiple
InJunes.
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One way to solve the question of whether resultant bladder hypertrophy from the
SCI is responsible for a change in P2X3 expression is to conduct a study where dorsal
root ganglia are collected from animals that received only a spinal cord injury. P2X3
expression results from qPCR for the LUL2 and L6/S 1 dorsal root ganglia from those
animals could show if P2X3 expression levels were reduced compared to naive giving a
possible indication that resultant bladder hypertrophy was acting as a primary injury.
While the mechanism of why P2X3 expression decreases following injury to
tissue and neurons is unknown, these results could be an indication of a pattern with a
variety of tissue injuries triggering a similar response. It is possible that A TF3 may have
something to do with the P2X3 regulation due to its putative binding site on the P2X3
gene. The trend can be seen that when ATF3 activation occurs, it is accompanied by a
decrease in the level of P2X3 mRNA expression in the dorsal root ganglia. This can be
seen in the LUL2 dorsal root ganglia where there is a significant increase in ATF3. It can
be observed that there is a slight decrease in the P2X3 expression levels for the acetic
acid treated animals as compared to naive. However, the L6/S 1 dorsal root ganglia do
not have a significant increase in ATF3 expression. The difference is L6/S 1 dorsal root
ganglia innervate the portion of the bladder that did not receive an incision. The mRNA
expression levels of ATF3 are not significantly increased but the P2X3 expression levels
trend towards being slightly elevated. While not significant this could fit the trend of
previous studies into the varied results of P2X3 expression levels with peripheral nerve
injury (Tsuzuki et aI., 2001). Increased ATF3 expression leads to a decrease in P2X3
levels in the injured neurons while the surrounding uninjured population of neurons in the
dorsal root ganglia express increased levels of P2X3 (Tsuzuki et aI., 2001). In this case
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the portion of the bladder corresponding to LIIL2 dorsal root ganglia innervation, the
dome, received an incision possibly resulting in increased neuronal injury leading to the
activation of more ATF3 positive neurons in the dorsal root ganglia slightly lowering the
levels of P2X3 mRNA expression in the LlIL2 dorsal root ganglia. However, in the
L6/S 1 dorsal root ganglia, there was not an incision made in the corresponding innervated
tissue leading to a non significant ATF3 activation and overall slightly increased P2X3
expression in the L6/S 1 dorsal root ganglia, which could be due to inflammation without
injury to the bladder.
Another consideration is that the abdominal incision that is required to place the
bladder catheter presumably injures neurons corresponding to the LIIL2 dorsal root
ganglia. This could increase ATF3 activation and mRNA expression in the LIIL2 dorsal
root ganglia. This could be addressed for by replicating the abdominal incision (without
bladder catheterization) in a group of animals and assessing ATF3 in the LIIL2 dorsal
root ganglia.
Another consideration that needs to taken into account is the fact that mRNA
expression of genes was being examined by qPCR in the whole dorsal root ganglia.
While there may be trends of increased or decreased expression in the dorsal root ganglia
as a whole it does not address the question of what is happening to gene expression
specifically in the injured neurons. Gene expression changes in these individual neurons
that have been injured may be significant while the whole dorsal root ganglion popUlation
is not. The gene expression changes in the injured neurons are important in terms of
tissue damage. Gene expression changes in injured neurons that could lead to
pathological changes in these sensory neurons are of interest.
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The nodose data does not give a clear indication that after SCI the vagus nerve is
exhibiting any type of neuronal plasticity indicating its possible innervation of the
bladder. However, it does not rule out a connection or a possible link to the incidence of
pelvic pain after clinically complete SCI. Anatomical studies have established a
connection between the vagus nerve and the rat bladder (unpublished data from Petruska,
Hubscher and Rau) and its role and pattern of innervation still need to be elucidated. The
role of the vagal innervation may be entirely different than spinal sensory innervation
making it unresponsive to injury and inflammation. Another thought is the percentage of
nodose neurons innervating the bladder is far too small to reach detection by our
methods. In anatomical tracer studies the percentage of neurons labeled by the tracer was
very small.
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SUMMARY AND CONCLUSIONS

We have found that tissue damage may not equal nerve injury but it appears to
mimic aspects of it. Its response may have important consequences in terms of
sensitization to injury. Repeated injury over time may lead to major havoc in the nervous
system and lead to bigger issues such as a transition from acute to chronic pain
syndromes in non-SCI patients and may exacerbate autonomic dysreflexia in SCI
patients.
Bladder incision and possibly inflammation results in injury to neurons and
alteration of expression of the nociceptive marker P2X3. This mayor may not indicate a
pathological process but it indicates that something is occurring that is different than in
naIve. Cutaneous tissue incision has also been shown to alter the level of P2X3. P2X3
plays a role in transduction of the release of ATP by injured tissues into a nociceptive
signal. P2X3 expression is shown to be down regulated after initial tissue injury. We
also have shown that following repeated injury it trends to increase slightly, an apparent
reversal from its regulation after single incision.
In the future a greater number of animals would be needed to understand whether
or not the trends found in the SCI group were true and possibly significant. There would
also be the need for a group of SCI animals without abdominal surgery and bladder
incision to determine if SCI with bladder dysfunction and hypertrophy is acting as a
primary injury and would be responsible for a decrease in P2X3 expression levels.
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An increase in P2X3 may possibly lead to a sensitization like effect in sending
more nociceptive signaling messages to the spinal cord. The more frequent the signal the
greater the intensity of the signal. While the mechanism is not fully understood an
alteration of P2X3 expression could be part of a pathological conditioning that leads to
problems such as chronic pain syndromes for our non SCI population and deadly bouts of
autonomic dysreflexia for our SCI population.
While we know the role P2X3 plays in terms of bladder function and nociceptive
signaling in the periphery, future studies will be necessary to understand the role that
P2X3 is playing in terms of changes in its levels of expression. Determining if repeated
insults to our cutaneous tissue is capable of bringing about a pathological condition is
something worth studying especially if understanding this mechanism can lead to the
possible decrease in chronic pain and other pathological pain states.
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